BridgeBio have substantially improved the progress of a novel solution for amyloid heart disease, leveraging Attruby. Preliminary patient information reveals potential outcomes for patients suffering by a debilitating disease. This emphasis highlights BridgeBio's dedication to managing critical healthcare needs in the heart space. Attruby: BridgeB